These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 11332210

  • 1. [SERM--selective estrogen receptor modulators].
    Kønig KB, Eiken PA, Schwarz P.
    Ugeskr Laeger; 2001 Apr 09; 163(15):2129-33. PubMed ID: 11332210
    [Abstract] [Full Text] [Related]

  • 2. Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health.
    Goldstein SR.
    Int J Fertil Womens Med; 1999 Apr 09; 44(5):221-6. PubMed ID: 10569450
    [Abstract] [Full Text] [Related]

  • 3. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL, Cheng MH, Chao HT, Wang PH.
    Taiwan J Obstet Gynecol; 2008 Mar 09; 47(1):24-31. PubMed ID: 18400579
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ, Craig Jordan V.
    Minerva Endocrinol; 2002 Jun 09; 27(2):127-39. PubMed ID: 11961504
    [Abstract] [Full Text] [Related]

  • 5. Selective estrogen-receptor modulators for primary prevention of breast cancer.
    Fabian CJ, Kimler BF.
    J Clin Oncol; 2005 Mar 10; 23(8):1644-55. PubMed ID: 15755972
    [No Abstract] [Full Text] [Related]

  • 6. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T, Mannella P, Genazzani AR.
    Recenti Prog Med; 2003 Feb 10; 94(2):51-6. PubMed ID: 12908369
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experience with raloxifene].
    Szúcs J, Pávó I, Jurida N.
    Orv Hetil; 2000 Jan 30; 141(5):237-40. PubMed ID: 10697982
    [Abstract] [Full Text] [Related]

  • 10. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
    Bevers TB.
    J Natl Compr Canc Netw; 2007 Sep 30; 5(8):719-24. PubMed ID: 17927929
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drugs can reduce the incidence of breast cancer: now what?
    Wozniak TF, Eppes PG, Wilson CT.
    Del Med J; 1999 Sep 30; 71(9):387-9. PubMed ID: 10584440
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.